C-reactive protein is a bystander of cardiovascular disease

Area of Science:

• Biomedical research
• Cardiovascular science
• Inflammation markers

Background:

• High-sensitivity C-reactive protein (hs-CRP) is a marker of inflammation.
• Numerous studies have explored the link between hs-CRP, atherosclerosis, and coronary heart disease (CHD).
• Existing research includes mechanistic, genetic, population-based studies, and clinical trials.

Purpose of the Study:

• To review and synthesize the collective evidence on the association between hs-CRP and atherosclerosis/CHD.
• To determine if hs-CRP plays a causal role in the development of atherosclerosis and CHD.
• To ascertain whether hs-CRP acts as a causal factor or a bystander in the disease pathway.

Main Methods:

• Systematic review of existing literature.
• Analysis of mechanistic, genetic, epidemiological, and clinical trial data.
• Evaluation of the association between hs-CRP levels and cardiovascular outcomes.

Main Results:

• The collective evidence is being reviewed to determine the role of hs-CRP.
• The findings will clarify whether hs-CRP is causally implicated in atherosclerosis and CHD.
• Distinguishing between a causal role and a bystander effect is the focus.

Conclusions:

• The review aims to provide a definitive conclusion on the causal role of hs-CRP in atherosclerosis and CHD.
• Understanding hs-CRP's role is crucial for cardiovascular disease risk assessment and management.
• The study will help differentiate between a biomarker and a therapeutic target.